Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents

NCT05343039 is registered in ClinicalTrials.gov with University of Notre Dame as lead sponsor.

NCT NCT05343039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents
Lead sponsor
University of Notre Dame
Phase
Not applicable
Overall status
Completed
Start date
September 6, 2022
Completion date
January 15, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, nonsuicidal self injury, vagus nerve stimulation